Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00149968
Status:
COMPLETED
Last Update Posted:
2020-02-11
First Post:
2005-09-06
Brief Title:
Measurement of Patient Reported Gastrointestinal GI and Health-related Quality of Life HRQL Outcomes in Renal Transplant Recipients MyLife
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Measurement of Patient Reported Gastrointestinal GI and Health-related Quality of Life HRQL Outcomes in Renal Transplant Recipients MyLife
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess whether a switch from mycophenolate mofetil MMF to enteric-coated mycophenolate sodium EC-MPS results in improved GI- andor health-related quality of life outcomes and to determine the proportion of renal transplant recipients who are experiencing any GI complaints under MMF-based immunosuppressive treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None